Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 5.4x - 5.9x | 5.7x |
| Selected Fwd Ps Multiple | 5.5x - 6.1x | 5.8x |
| Fair Value | ₩12,983 - ₩14,349 | ₩13,666 |
| Upside | 31.1% - 44.9% | 38.0% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Miwon Commercial Co., Ltd. | - | KOSE:A002840 |
| Cell Bio Human Tech Co.,Ltd | - | KOSDAQ:A318160 |
| KNW Co., Ltd. | - | KOSDAQ:A105330 |
| Nano Chem Tech Inc. | - | KOSDAQ:A091970 |
| Miwon Chemicals Co., Ltd. | - | KOSE:A134380 |
| Kumyang Co., Ltd. | - | KOSE:A001570 |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| A002840 | A318160 | A105330 | A091970 | A134380 | A001570 | |||
| KOSE:A002840 | KOSDAQ:A318160 | KOSDAQ:A105330 | KOSDAQ:A091970 | KOSE:A134380 | KOSE:A001570 | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | 11.8% | 3.3% | -3.3% | 3.2% | 10.6% | -2.3% | ||
| 3Y CAGR | 6.6% | -6.9% | 3.0% | 5.7% | 9.1% | -10.9% | ||
| Latest Twelve Months | 5.3% | 9.9% | -9.0% | 15.9% | 8.2% | -0.5% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 15.2% | 5.6% | 1.2% | -22.9% | 8.2% | -31.5% | ||
| Prior Fiscal Year | 14.5% | -6.8% | 2.2% | -10.7% | 9.4% | -39.7% | ||
| Latest Fiscal Year | 11.6% | 15.4% | 4.4% | -6.7% | 10.5% | -91.1% | ||
| Latest Twelve Months | 12.5% | 16.6% | 1.0% | -8.3% | 9.8% | -96.6% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 7.4x | 7.6x | 54.6x | 15.5x | 2.4x | -26.9x | ||
| Price / LTM Sales | 1.8x | 2.0x | 0.9x | 0.4x | 0.6x | 4.2x | ||
| LTM P/E Ratio | 14.0x | 11.8x | 95.5x | -5.2x | 6.3x | -4.3x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 0.4x | 0.9x | 2.0x | |||||
| Historical LTM P/S Ratio | 1.1x | 6.2x | 39.4x | |||||
| Selected Price / Sales Multiple | 5.4x | 5.7x | 5.9x | |||||
| (x) LTM Sales | 151,300 | 151,300 | 151,300 | |||||
| (=) Equity Value | 813,499 | 856,315 | 899,131 | |||||
| (/) Shares Outstanding | 63.8 | 63.8 | 63.8 | |||||
| Implied Value Range | 12,742.27 | 13,412.91 | 14,083.56 | |||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 12,742.27 | 13,412.91 | 14,083.56 | 9,900.00 | ||||
| Upside / (Downside) | 28.7% | 35.5% | 42.3% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | A002840 | A318160 | A105330 | A091970 | A134380 | A001570 | |
| Value of Common Equity | 771,265 | 60,333 | 75,861 | 22,515 | 160,128 | 632,041 | |
| (/) Shares Outstanding | 4.6 | 8.3 | 15.9 | 36.1 | 2.0 | 63.8 | |
| Implied Stock Price | 166,600.00 | 7,300.00 | 4,780.00 | 623.00 | 79,300.00 | 9,900.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 166,600.00 | 7,300.00 | 4,780.00 | 623.00 | 79,300.00 | 9,900.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |